Fact CheckerSign in

NCT06840522Not yet recruiting

The Importance of Tailored Education And Device Handling for Asthmatic Patients

Source: ClinicalTrials.gov · Last updated 24 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Significant advancements have been made in asthma medication over the past decades. Highly effective treatments are available for patients; however, both adherence and proper device usage remain below the desired levels, based on our experience and literature data. Despite the availability of numerous excellent drug-device combinations, personalized treatment for patients is still not adequately addressed. In the present study, the aim is to improve patient compliance and educate symptomatic, partially, or uncontrolled asthma patients on the correct use of a specific inhalation device (Nexthaler). Considering the characteristics of the medication, the patient's lung function data, inhalation technique, and drug retention time can help estimate the expected lung deposition of the medication. By refining the inhalation technique under the guidance of the treating physician, it is hypothesized that the expected therapeutic effects of the medication may improve.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
250 (estimated)
First submitted
18 Feb 2025
Start date
1 Mar 2025
Primary completion date
1 Jun 2026
Lead sponsor
Chiesi Hungary Ltd.
Diseases
Asthma
NCT number
NCT06840522

What you commit to

  • Study type: Observational
  • Planned participants: 250
  • From 1 Mar 2025 to the primary completion date, 1 Jun 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in any clinical trial, 30 days prior to inclusion
  • Patients hospitalized due to an exacerbation of their asthma within the last 4 weeks prior to enrolment.
  • Continuous use of oral corticosteroids (\>5 mg prednisolone/day or \>4 mg methylprednisolone/day)
  • Use of continuous oxygen therapy

Other illness

  • Patients with other significant diseases of the respiratory system or other organ systems that may significantly contribute to asthma symptoms (such as severe heart failure, symptomatic anaemia, functional respiratory disorders, malignant diseases etc.) according to the physician's clinical assessment.

Other

  • Patient is unable to execute a spirometry test
  • Use of biologics for asthma treatment
  • All exclusion criteria listed in Foster Nexthaler 100/6 SmPC

Who the study is looking for

  • Physician-confirmed clinical diagnosis of asthma according to GINA guidelines
  • Uncontrolled asthma according to the physician's clinical assessment despite the use of appropriate therapy of Step 2 or 3, according to GINA guidelines
  • Patients who are eligible for the use of Foster Nexthaler 100/6 mcg according to the SmPC
  • Inhaled asthma therapy was changed independent from the study to Foster Nexthaler 100/6 mcg DPI maximum 1 week prior to OR on the day of study inclusion
  • Spirometry was performed as part of routine clinical practice
  • Patient able to use their Foster Nexthaler device properly after education on inhaler technique
  • Patient provided written, informed consent to study participation
  • Patient ≥ 18 years of age

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Korányi Institute of Pulmonology
Coordinator of this site? Confirm its status
BudapestHungaryUnknown status
Department of Pulmonology and Allergology, Csornai MArgit Hospital
Coordinator of this site? Confirm its status
CsornaHungaryUnknown status
Department of Pulmonology, Debrecen University
Coordinator of this site? Confirm its status
DebrecenHungaryUnknown status
Pulmonology Outpatient Clinic of Dunakeszi
Coordinator of this site? Confirm its status
DunakesziHungaryUnknown status
Department of Pulmonology, University of Szeged
Coordinator of this site? Confirm its status
SzegedHungaryUnknown status
Calvinist Pulmonology Centre
Coordinator of this site? Confirm its status
TörökbálintHungaryUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.